422 related articles for article (PubMed ID: 26392430)
1. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
[TBL] [Abstract][Full Text] [Related]
2. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL
Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200
[TBL] [Abstract][Full Text] [Related]
3. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.
Miller BS; Gauger PG; Hammer GD; Giordano TJ; Doherty GM
Langenbecks Arch Surg; 2010 Sep; 395(7):955-61. PubMed ID: 20694732
[TBL] [Abstract][Full Text] [Related]
4. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
[TBL] [Abstract][Full Text] [Related]
5. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
6. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
[TBL] [Abstract][Full Text] [Related]
7. The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
Liang J; Liu Z; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Wei X; Lu Y; Zhu Y
Endocrine; 2020 Feb; 67(2):449-456. PubMed ID: 31786772
[TBL] [Abstract][Full Text] [Related]
8. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database.
Tella SH; Kommalapati A; Yaturu S; Kebebew E
J Clin Endocrinol Metab; 2018 Sep; 103(9):3566-3573. PubMed ID: 29982685
[TBL] [Abstract][Full Text] [Related]
10. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32449514
[TBL] [Abstract][Full Text] [Related]
11. Resection of adrenocortical carcinoma liver metastasis: is it justified?
Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection of synchronously metastatic adrenocortical cancer.
Dy BM; Strajina V; Cayo AK; Richards ML; Farley DR; Grant CS; Harmsen WS; Evans DB; Grubbs EG; Bible KC; Young WF; Perrier ND; Que FG; Nagorney DM; Lee JE; Thompson GB
Ann Surg Oncol; 2015 Jan; 22(1):146-51. PubMed ID: 25092161
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.
Jouinot A; Assie G; Libe R; Fassnacht M; Papathomas T; Barreau O; de la Villeon B; Faillot S; Hamzaoui N; Neou M; Perlemoine K; Rene-Corail F; Rodriguez S; Sibony M; Tissier F; Dousset B; Sbiera S; Ronchi C; Kroiss M; Korpershoek E; de Krijger R; Waldmann J; K D; Bartsch ; Quinkler M; Haissaguerre M; Tabarin A; Chabre O; Sturm N; Luconi M; Mantero F; Mannelli M; Cohen R; Kerlan V; Touraine P; Barrande G; Groussin L; Bertagna X; Baudin E; Amar L; Beuschlein F; Clauser E; Coste J; Bertherat J
J Clin Endocrinol Metab; 2017 Mar; 102(3):923-932. PubMed ID: 27967600
[TBL] [Abstract][Full Text] [Related]
14. Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical Carcinoma.
Boilève A; Mathy E; Roux C; Faron M; Hadoux J; Tselikas L; Al Ghuzlan A; Hescot S; Leboulleux S; de Baere T; Lamartina L; Deschamps F; Baudin E
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4698-e4707. PubMed ID: 34143888
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature.
Mpaili E; Moris D; Tsilimigras DI; Oikonomou D; Pawlik TM; Schizas D; Papalampros A; Felekouras E; Dimitroulis D
J Laparoendosc Adv Surg Tech A; 2018 Apr; 28(4):408-414. PubMed ID: 29319399
[TBL] [Abstract][Full Text] [Related]
16. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation.
Lughezzani G; Sun M; Perrotte P; Jeldres C; Alasker A; Isbarn H; Budäus L; Shariat SF; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Cancer; 2010 Mar; 46(4):713-9. PubMed ID: 20044246
[TBL] [Abstract][Full Text] [Related]
17. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
[TBL] [Abstract][Full Text] [Related]
18. Clinical Score Predicting Overall Survival After Surgery for Synchronous Metastatic Adrenocortical Carcinoma: A Surveillance, Epidemiology, and End Result-Based Study.
Wu K; Liu Z; Li X; Lu Y
Am Surg; 2021 May; 87(5):805-811. PubMed ID: 33228399
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.
Reibetanz J; Rinn B; Kunz AS; Flemming S; Ronchi CL; Kroiss M; Deutschbein T; Pulzer A; Hahner S; Kocot A; Germer CT; Fassnacht M; Jurowich C
Ann Surg Oncol; 2019 Feb; 26(2):531-538. PubMed ID: 30443830
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
